ZARNESYL Trademark

Trademark Overview

On Thursday, August 12, 2004, a trademark application was filed for ZARNESYL with the United States Patent and Trademark Office. The USPTO has given the ZARNESYL trademark a serial number of 78466173. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, July 25, 2008. This trademark is owned by Johnson & Johnson. The ZARNESYL trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceuticals, namely, anti-cancer drugs
zarnesyl

General Information

Serial Number78466173
Word MarkZARNESYL
Filing DateThursday, August 12, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, July 25, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2005

Trademark Statements

Goods and Serviceshuman pharmaceuticals, namely, anti-cancer drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 20, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Thursday, September 25, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, September 25, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 12, 2008EXTENSION 4 GRANTED
Wednesday, January 23, 2008EXTENSION 4 FILED
Wednesday, January 23, 2008PAPER RECEIVED
Monday, July 23, 2007EXTENSION 3 GRANTED
Monday, July 23, 2007EXTENSION 3 FILED
Monday, July 23, 2007TEAS EXTENSION RECEIVED
Thursday, January 18, 2007EXTENSION 2 GRANTED
Thursday, January 18, 2007EXTENSION 2 FILED
Thursday, January 18, 2007TEAS EXTENSION RECEIVED
Friday, July 21, 2006EXTENSION 1 GRANTED
Friday, July 21, 2006EXTENSION 1 FILED
Friday, July 21, 2006TEAS EXTENSION RECEIVED
Tuesday, January 24, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2005NOTICE OF PUBLICATION
Wednesday, September 7, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 26, 2005ASSIGNED TO LIE
Friday, August 19, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 5, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 28, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 28, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 28, 2005NON-FINAL ACTION MAILED
Thursday, January 27, 2005NON-FINAL ACTION WRITTEN
Wednesday, January 26, 2005ASSIGNED TO EXAMINER
Friday, August 20, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

zarnesyl cancer drugs anti namely pharmaceuticals human